These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8536660)

  • 81. [Investigations on the acute, carrageenan-induced inflammatory reaction and pharmacology of orally administered sodium salicylate in turkeys].
    Cramer K; Schmidt V; Richter A; Fuhrmann H; Abraham G; Krautwald-Junghanns ME
    Berl Munch Tierarztl Wochenschr; 2015; 128(5-6):240-51. PubMed ID: 26054231
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacokinetics of ketoprofen in the donkey (Equus asinus).
    Oukessou M; Bouljihad M; Van Gool F; Alvinerie M
    Zentralbl Veterinarmed A; 1996 Sep; 43(7):423-6. PubMed ID: 8921728
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Actions of BW540C in an equine model of acute inflammation: a preliminary study.
    Higgins AJ; Lees P; Sedgwick AD
    Vet Q; 1987 Apr; 9(2):103-10. PubMed ID: 3039716
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin.
    Lees P; Ewins CP; Taylor JB; Sedgwick AD
    Br Vet J; 1987; 143(5):462-76. PubMed ID: 3119142
    [No Abstract]   [Full Text] [Related]  

  • 85. Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants.
    Moses VS; Hardy J; Bertone AL; Weisbrode SE
    Am J Vet Res; 2001 Jan; 62(1):54-60. PubMed ID: 11197561
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses.
    Lee CD; Maxwell LK
    J Vet Pharmacol Ther; 2014 Feb; 37(1):35-42. PubMed ID: 23659780
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacokinetics and pharmacodynamics of fenleuton, a 5-lipoxygenase inhibitor, in ponies.
    Marr K; Marsh K; Hernandez L; Cunningham FM; Lees P
    Res Vet Sci; 1998; 64(2):111-7. PubMed ID: 9625466
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The pharmacokinetics of flunixin meglumine in the sheep.
    Welsh EM; McKellar QA; Nolan AM
    J Vet Pharmacol Ther; 1993 Jun; 16(2):181-8. PubMed ID: 8345568
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacokinetic interactions between flunixin and sulphadimidine in horses.
    el-Banna HA
    Dtsch Tierarztl Wochenschr; 1999 Sep; 106(9):400-3. PubMed ID: 10547934
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation.
    Pelligand L; King JN; Toutain PL; Elliott J; Lees P
    J Vet Pharmacol Ther; 2012 Feb; 35(1):19-32. PubMed ID: 21767277
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling.
    Toutain PL; Autefage A; Legrand C; Alvinerie M
    J Vet Pharmacol Ther; 1994 Dec; 17(6):459-69. PubMed ID: 7707492
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse.
    Lees P; Taylor JB; Higgins AJ; Sharma SC
    J Vet Pharmacol Ther; 1986 Jun; 9(2):204-12. PubMed ID: 3723663
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses.
    Holland B; Fogle C; Blikslager AT; Curling A; Barlow BM; Schirmer J; Davis JL
    J Vet Pharmacol Ther; 2015 Jun; 38(3):249-56. PubMed ID: 25378135
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacokinetics and pharmacodynamic effects of flunixin after intravenous, intramuscular and oral administration to dairy goats.
    Königsson K; Törneke K; Engeland IV; Odensvik K; Kindahl H
    Acta Vet Scand; 2003; 44(3-4):153-9. PubMed ID: 15074628
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Flunixin pharmacokinetics and serum thromboxane inhibition in the dog.
    McKellar QA; Galbraith EA; Bogan JA; Russell CS; Hooke RE; Lees P
    Vet Rec; 1989 Jun; 124(25):651-4. PubMed ID: 2763429
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Enantioselective pharmacokinetics of ketoprofen in calves after intramuscular administration of a racemic mixture.
    Plessers E; Watteyn A; Wyns H; Pardon B; De Baere S; De Backer P; Croubels S
    J Vet Pharmacol Ther; 2015 Aug; 38(4):410-3. PubMed ID: 25410631
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacokinetics of transdermal flunixin meglumine and effects on biomarkers of inflammation in horses.
    Knych HK; Arthur RM; Gretler SR; McKemie DS; Goldin S; Kass PH
    J Vet Pharmacol Ther; 2021 Sep; 44(5):745-753. PubMed ID: 34173263
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of flunixin meglumine on selected physiologic and performance parameters of athletically conditioned thoroughbred horses subjected to an incremental exercise stress test.
    Colahan PT; Bailey JE; Chou CC; Johnson M; Rice BL; Jones GL; Cheeks JP
    Vet Ther; 2002; 3(1):37-48. PubMed ID: 12050827
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis.
    Główka F; Karaźniewicz-Łada M; Grześkowiak E; Rogozinska D; Romanowski W
    Eur J Drug Metab Pharmacokinet; 2011 Sep; 36(3):167-73. PubMed ID: 21516380
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Randomised trial of the bioavailability and efficacy of orally administered flunixin, carprofen and ketoprofen in a pain model in sheep.
    Marini D; Pippia J; Colditz IG; Hinch G; Petherick JC; Lee C
    Aust Vet J; 2015 Aug; 93(8):265-70. PubMed ID: 26220318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.